TrialPain2017

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial.

Annette Christoph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.